Terms: = Germ cell tumor AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Diagnosis
23 results:
1. Treatment-related Neuroendocrine Prostate Carcinoma-Diagnostic and Molecular Correlates.
Gopalan A
Adv Anat Pathol; 2024 Mar; 31(2):70-79. PubMed ID: 38223983
[TBL] [Abstract] [Full Text] [Related]
2. Combined Inhibition of ezh2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.
Badhai J; Landman N; Pandey GK; Song JY; Hulsman D; Krijgsman O; Chandrasekaran G; Berns A; van Lohuizen M
Cancer Res Commun; 2024 Jan; 4(1):18-27. PubMed ID: 38054839
[TBL] [Abstract] [Full Text] [Related]
3. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
Quddusi DM; Bajcinca N
IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
[TBL] [Abstract] [Full Text] [Related]
4. EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
Jenseit A; Camgöz A; Pfister SM; Kool M
Acta Neuropathol; 2022 Jan; 143(1):1-13. PubMed ID: 34762160
[TBL] [Abstract] [Full Text] [Related]
5. Combination LSD1 and HOTAIR-ezh2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells.
Zhao J; Jin W; Yi K; Wang Q; Zhou J; Tan Y; Xu C; Xiao M; Hong B; Xu F; Zhang K; Kang C
Pharmacol Res; 2021 Sep; 171():105764. PubMed ID: 34246782
[TBL] [Abstract] [Full Text] [Related]
6. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with ezh2.
Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and Biological Features of Neuroendocrine Prostate Cancer.
Yamada Y; Beltran H
Curr Oncol Rep; 2021 Jan; 23(2):15. PubMed ID: 33433737
[TBL] [Abstract] [Full Text] [Related]
8. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme.
Jiang L; Zhong M; Chen T; Zhu X; Yang H; Lv K
J Cell Mol Med; 2020 Sep; 24(17):10075-10087. PubMed ID: 32696617
[TBL] [Abstract] [Full Text] [Related]
9. Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (ezh2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma.
Sasaki T; Katagi H; Goldman S; Becher OJ; Hashizume R
Neurosurgery; 2020 Nov; 87(6):E680-E688. PubMed ID: 32674144
[TBL] [Abstract] [Full Text] [Related]
10. Expression and prognostic role of E2F transcription factors in high-grade glioma.
Yu H; Li Z; Wang M
CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA TTBK2 promotes the development of human glioma cells via miR-520b/ezh2 axis.
Yuan DH; Zhao J; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10886-10898. PubMed ID: 31858557
[TBL] [Abstract] [Full Text] [Related]
12. Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG).
Giagnacovo M; Antonelli M; Biassoni V; Schiavello E; Warmuth-Metz M; Buttarelli FR; Modena P; Massimino M
Childs Nerv Syst; 2020 Apr; 36(4):697-704. PubMed ID: 31848724
[TBL] [Abstract] [Full Text] [Related]
13. Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience.
Pfaff E; El Damaty A; Balasubramanian GP; Blattner-Johnson M; Worst BC; Stark S; Witt H; Pajtler KW; van Tilburg CM; Witt R; Milde T; Jakobs M; Fiesel P; Frühwald MC; Hernáiz Driever P; Thomale UW; Schuhmann MU; Metzler M; Bochennek K; Simon T; Dürken M; Karremann M; Knirsch S; Ebinger M; von Bueren AO; Pietsch T; Herold-Mende C; Reuss DE; Kiening K; Lichter P; Eggert A; Kramm CM; Pfister SM; Jones DTW; Bächli H; Witt O
Eur J Cancer; 2019 Jun; 114():27-35. PubMed ID: 31022591
[TBL] [Abstract] [Full Text] [Related]
14. Is Resection of Primary Midgut Neuroendocrine tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
[TBL] [Abstract] [Full Text] [Related]
15. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Pajtler KW; Wen J; Sill M; Lin T; Orisme W; Tang B; Hübner JM; Ramaswamy V; Jia S; Dalton JD; Haupfear K; Rogers HA; Punchihewa C; Lee R; Easton J; Wu G; Ritzmann TA; Chapman R; Chavez L; Boop FA; Klimo P; Sabin ND; Ogg R; Mack SC; Freibaum BD; Kim HJ; Witt H; Jones DTW; Vo B; Gajjar A; Pounds S; Onar-Thomas A; Roussel MF; Zhang J; Taylor JP; Merchant TE; Grundy R; Tatevossian RG; Taylor MD; Pfister SM; Korshunov A; Kool M; Ellison DW
Acta Neuropathol; 2018 Aug; 136(2):211-226. PubMed ID: 29909548
[TBL] [Abstract] [Full Text] [Related]
16. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
[TBL] [Abstract] [Full Text] [Related]
17. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract] [Full Text] [Related]
18. MELK and ezh2 Cooperate to Regulate Medulloblastoma Cancer Stem-like cell Proliferation and Differentiation.
Liu H; Sun Q; Sun Y; Zhang J; Yuan H; Pang S; Qi X; Wang H; Zhang M; Zhang H; Yu C; Gu C
Mol Cancer Res; 2017 Sep; 15(9):1275-1286. PubMed ID: 28536141
[TBL] [Abstract] [Full Text] [Related]
19. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
[TBL] [Abstract] [Full Text] [Related]
20. Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment.
Nord C; Olofsson SE; Glimelius I; Cedermark GC; Ekberg S; Cavallin-Ståhl E; Neovius M; Jerkeman M; Smedby KE
Acta Oncol; 2015 Nov; 54(10):1770-80. PubMed ID: 25833328
[TBL] [Abstract] [Full Text] [Related]
[Next]
